RECOVERY is a randomised trial investigating whether treatment with Lopinavir-Ritonavir, Hydroxychloroquine, Corticosteroids, Azithromycin, Colchicine, IV Immunoglobulin (children only), Convalescent plasma, Casirivimab+Imdevimab, Tocilizumab, Aspirin, Baricitinib, Infliximab, Empagliflozin, Sotrovimab, Molnupiravir, Paxlovid or Anakinra (children only) prevents death in patients with COVID-19. This data package contains patients randomized to the Tocilizumab comparison.
DOI Created: Thu, 27 Jul 2023 15:51:53 GMT
DOI Updated: Mon, 24 Mar 2025 10:06:30 GMT
University of Oxford, & University of Oxford. (2023). RECOVERY Trial Tocilizumab comparison [Data set]. the Infectious Diseases Data Observatory. https://doi.org/10.48688/K8Y0-S355
